Exogenous Mitochondrial Pretreatment Enhances the Therapeutic Effect of UC-MSCs on NAFLD in Type 2 Diabetic Mice by Mediating Mitochondrial Transfer.

Stem Cells Int · 2025 · PMC12401616 · PMID 40900739

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

Compared with MSCs, ALT decreased significantly in the mito-MSCs group; AST showed a decreasing trend, but there was no significant difference.

also in 47,180 other papers

showed a trendno p-value reported

Compared with steatosis, the pretreatment group in this study showed a trend but not significant improvement in the therapeutic function of MSCs in terms of swelling and inflammation.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.